Express Pharma
Home  »  Deals  »  Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets

Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets

Hikma had said in January that it was planning to buy those assets

0 218
Read Article

Hikma Pharmaceuticals and GlaxoSmithKline have ended talks over a potential buyout deal for the latter’s pharma, consumer commercialisation and manufacturing business in Egypt and its drugs business in Tunisia, the companies said.

Hikma, which supplies generic drugs including anaesthetics, pain medications, sedatives, neuromuscular blocking agents and anti-infectives, had said in January it was planning to buy those assets.

(Edits by EP News Bureau)

Leave A Reply

Your email address will not be published.

 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Attend India's Largest Pharma Packaging & Labelling Conclave
Register Now
close-image